I Thought Of Moderna, Inc. (MRNA) After Florida's Vaccine Rules, Says Jim Cramer

We recently published 10 Stocks Jim Cramer Discussed As He Warned About Big Risk To Big Tech. Moderna, Inc. (NASDAQ:MRNA) is one of the stocks Jim Cramer recently discussed.

Moderna, Inc. (NASDAQ:MRNA) is the ill-fated vaccine company that has continued to struggle after the COVID-19 pandemic’s end. Its shares have lost 42% year-to-date and a whopping 94% since their 2021 peak. Cramer’s previous comments about Moderna, Inc. (NASDAQ:MRNA) have refused to believe that there is no value in the firm and wondered whether its price target should be $18. This time, he discussed the firm in the context of recent developments surrounding vaccination requirements:

“[On Florida removing vaccination requirements and other states doing their own thing] Yeah, like I was looking at Moderna, how much they’re involved and maybe, they’re under a lot of pressure, I know Pfizer. . .But I think that these are very politicized. You heard from RFK, it’s a very small group of people who I guess should we say have to worry about it.”

Here are Cramer’s recent thoughts about Moderna, Inc. (NASDAQ:MRNA):

“Hey that’s got the double whammy. It’s vaccine, got a guy at HHS doesn’t like it, they never did anything with the other one.”

While we acknowledge the potential of MRNA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.